Trial Profile
Effect of BMS-663068 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Acetate in Healthy Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Fostemsavir (Primary) ; Estradiol/progestogen; Ethinylestradiol/norethisterone
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 08 Oct 2020 Results applying data from this and other antiretroviral contraceptive studies assessing coadministraion of hormones with Fostemsavir, presented at the 15th International Congress on Drug Therapy and HIV Infection
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science
- 02 May 2016 Status changed from active, no longer recruiting to completed.